Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Annual General Meeting 2018 – GN Store Nord A/S


Posted on: 13 Mar 18

Today, GN Store Nord A/S held its annual general meeting in accordance with the agenda
announced on February 19, 2018.

The report by the board of directors was adopted, and both the Annual Report 2017 and the
proposal to distribute dividends of DKK 1.25 per share of nominally DKK 4 were approved.

The general meeting approved the remuneration to the board of directors of DKK 7,342,500 for
2018.

Per Wold-Olsen, William E. Hoover, Jr., Wolfgang Reim, Hélène Barnekow and Ronica Wang were re-elected and Gitte Pugholm Aabo was elected to the board of directors by the general meeting. 

Furthermore, Ernst & Young Godkendt Revisionspartnerselskab was re-elected as the company’s
auditor and all proposals by the board of directors were approved.

At the following constituting board meeting, Per Wold-Olsen was elected chairman of the board of
directors, and William E. Hoover, Jr. was elected deputy chairman of the board of directors. 

Per Wold-Olsen was also elected as chairman of the remuneration committee and the nomination
committee. Gitte Pugholm Aabo was elected as chairman of the audit committee, and Wolfgang Reim was elected as chairman of the strategy committee.

Agenda for the annual general meeting:
a)Report by the board of directors on the activities of the company during the past year.
b)Submission of the audited annual report for adoption and resolution of discharge to the board of directors and the executive board.
c)Decision on application of profits or covering of losses in accordance with the approved annual report.
d)Approval of the remuneration to the board of directors for the current financial year.
e)Election of members to the board of directors.
f)Election of a state-authorized public accountant to serve until the company’s next annual general meeting.
g)Proposals from the board of directors and shareholders.
g.1Proposals from the board of directors.
g.1.1Proposal from the board of directors to authorize the board of directors to acquire treasury shares.
g.1.2Proposal from the board of directors to renew and increase the authorization to the board of directors to increase the share capital.
g.1.3Proposal from the board of directors to amend the remuneration policy, including general guidelines for incentive pay.
g.1.4Proposal by the board of directors to prepare company announcements in English.
g.2Proposals from shareholders.
h)Any other business.

For further information, please contact:

Investors and analysts
Peter Justesen
VP – Investor Relations & Treasury
Tel: +45 45 75 87 16

Or

Rune Sandager
Senior IR Manager – Investor Relations & Treasury
Tel: +45 45 75 92 57

Press and the media
Lars Otto Andersen-Lange
Group Media Manager
Tel: +45 45 75 02 55


About GN Group
The GN Group is a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. With our unique competencies within medical, professional and consumer audio solutions, we transform lives through the power of sound: Hearing aids that enhance the lives of people with hearing loss; integrated headset and communications solutions that assist professionals in all types of businesses to be more productive; wireless headsets and earbuds designed to support calls, music and media consumption.

With world leading expertise in the human ear, sound, wireless technology and miniaturization, GN’s innovative and intelligent audio solutions are marketed by the brands ReSound, Beltone, Interton, Jabra and Blueparrott in 100 countries across the world. Founded in 1869, the GN Group today has more than 5,500 employees and is listed on Nasdaq Copenhagen (GN.CO).

Visit our homepage GN.com - and connect with us on LinkedIn, Facebook and Twitter.

Announcement 14 - Annual General Meeting 2018

GlobeNewswire
globenewswire.com

Last updated on: 13/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.